메뉴 건너뛰기




Volumn 262, Issue 4, 2015, Pages 1024-1034

Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study

Author keywords

Aggressive multiples sclerosis; Alemtuzumab; Mitoxantrone; Rescue therapy

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; MITOXANTRONE; MONOCLONAL ANTIBODY;

EID: 84939973524     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-015-7653-3     Document Type: Article
Times cited : (20)

References (11)
  • 1
    • 54949143968 scopus 로고    scopus 로고
    • Alemtuzumab vs. interferon beta-1a in early multiple sclerosis
    • The CAMMS223 Trial Investigators (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 359:1786–1801. doi:10.1056/NEJMoa0802670
    • (2008) N Engl J Med , vol.359 , pp. 1786-1801
    • The CAMMS223 Trial Investigators1
  • 2
    • 84869492471 scopus 로고    scopus 로고
    • Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomized controlled phase 3 trial
    • COI: 1:CAS:528:DC%2BC38Xhs1ajtbjE, PID: 23122652
    • Cohen JA, Coles AJ, Arnold DL et al (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomized controlled phase 3 trial. Lancet 380:1819–1828
    • (2012) Lancet , vol.380 , pp. 1819-1828
    • Cohen, J.A.1    Coles, A.J.2    Arnold, D.L.3
  • 3
    • 84869507357 scopus 로고    scopus 로고
    • Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomized phase 3 trial
    • COI: 1:CAS:528:DC%2BC38Xhs1ajtbjF, PID: 23122650
    • Coles AJ, Twyman CL, Arnold DL et al (2012) Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomized phase 3 trial. Lancet 380:1829–1839
    • (2012) Lancet , vol.380 , pp. 1829-1839
    • Coles, A.J.1    Twyman, C.L.2    Arnold, D.L.3
  • 4
    • 0032882173 scopus 로고    scopus 로고
    • Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
    • COI: 1:CAS:528:DyaK1MXmtF2qtr4%3D, PID: 10482259
    • Coles AJ, Wing M, Molyneux P et al (1999) Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 46:296–304
    • (1999) Ann Neurol , vol.46 , pp. 296-304
    • Coles, A.J.1    Wing, M.2    Molyneux, P.3
  • 5
    • 0028346432 scopus 로고
    • Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis
    • COI: 1:STN:280:DyaK2czivVOmuw%3D%3D, PID: 7914262
    • Moreau T, Thorpe J, Miller D et al (1994) Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet 344:298–301
    • (1994) Lancet , vol.344 , pp. 298-301
    • Moreau, T.1    Thorpe, J.2    Miller, D.3
  • 6
    • 31544467633 scopus 로고    scopus 로고
    • The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy
    • PID: 16044212
    • Coles AJ, Cox A, Le Page E et al (2006) The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 253:98–108
    • (2006) J Neurol , vol.253 , pp. 98-108
    • Coles, A.J.1    Cox, A.2    Le Page, E.3
  • 7
    • 78650093744 scopus 로고    scopus 로고
    • Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis
    • COI: 1:CAS:528:DC%2BC3MXmvVKhsg%3D%3D, PID: 20810516
    • Esposito F, Radaelli M, Martinelli V et al (2010) Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 16:1490–1499
    • (2010) Mult Scler , vol.16 , pp. 1490-1499
    • Esposito, F.1    Radaelli, M.2    Martinelli, V.3
  • 8
    • 0031040238 scopus 로고    scopus 로고
    • Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicenter study of active disease using MRI and clinical criteria
    • COI: 1:STN:280:DyaK2s3gtVyrsg%3D%3D, PID: 9048709
    • Edan G, Miller D, Clanet M et al (1997) Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicenter study of active disease using MRI and clinical criteria. J Neurol Neurosurg Psychiatry 62:112–118
    • (1997) J Neurol Neurosurg Psychiatry , vol.62 , pp. 112-118
    • Edan, G.1    Miller, D.2    Clanet, M.3
  • 9
    • 37749016994 scopus 로고    scopus 로고
    • Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients
    • PID: 17846110
    • Le Page E, Leray E, Taurin G et al (2008) Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. J Neurol Neurosurg Psychiatry 79:52–56
    • (2008) J Neurol Neurosurg Psychiatry , vol.79 , pp. 52-56
    • Le Page, E.1    Leray, E.2    Taurin, G.3
  • 10
    • 80855131644 scopus 로고    scopus 로고
    • Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial
    • COI: 1:STN:280:DC%2BC38%2Fls12guw%3D%3D, PID: 21436229
    • Edan G, Comi C, Le Page E et al (2011) Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial. J Neurol Neurosurg Psychiatry 82:1344–1350
    • (2011) J Neurol Neurosurg Psychiatry , vol.82 , pp. 1344-1350
    • Edan, G.1    Comi, C.2    Le Page, E.3
  • 11
    • 77954382272 scopus 로고    scopus 로고
    • Evidence of a two stage disability progression in multiple sclerosis
    • PID: 20423930
    • Leray E, Yaouanq J, Le Page E et al (2010) Evidence of a two stage disability progression in multiple sclerosis. Brain 133:1900–1913
    • (2010) Brain , vol.133 , pp. 1900-1913
    • Leray, E.1    Yaouanq, J.2    Le Page, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.